
### [NCIT:C3641](http://purl.obolibrary.org/obo/NCIT_C3641)
**Label:** Stage 0 Breast Cancer AJCC v6 and v7

**Subclasses:** [NCIT:C4018](http://purl.obolibrary.org/obo/NCIT_C4018) (Lobular Breast Carcinoma In Situ), [NCIT:C5137](http://purl.obolibrary.org/obo/NCIT_C5137) (Intraductal Non-Comedo Breast Adenocarcinoma), [NCIT:C5138](http://purl.obolibrary.org/obo/NCIT_C5138) (Intraductal Cribriform Breast Adenocarcinoma), [NCIT:C2924](http://purl.obolibrary.org/obo/NCIT_C2924) (Ductal Breast Carcinoma In Situ), [NCIT:C66933](http://purl.obolibrary.org/obo/NCIT_C66933) (Ductal Breast Carcinoma In Situ, Solid Type), [NCIT:C4195](http://purl.obolibrary.org/obo/NCIT_C4195) (Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ), [NCIT:C137839](http://purl.obolibrary.org/obo/NCIT_C137839) (Pleomorphic Lobular Breast Carcinoma In Situ), 

**Class expressions from DL-Learner:**

- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C37867](http://purl.obolibrary.org/obo/NCIT_C37867) (Tetrasomy 7))) 56.94%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C36600](http://purl.obolibrary.org/obo/NCIT_C36600) (Tetrasomy 12))) 56.94%
- [NCIT:C36657](http://purl.obolibrary.org/obo/NCIT_C36657) (Polysomy 17) 54.55%
- [NCIT:C36656](http://purl.obolibrary.org/obo/NCIT_C36656) (Polysomy 10) 54.55%
- [NCIT:C36655](http://purl.obolibrary.org/obo/NCIT_C36655) (Polysomy 3) 54.55%
- Thing 52.70%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 52.37%
- [NCIT:C36331](http://purl.obolibrary.org/obo/NCIT_C36331) (Polysomy) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 52.37%


